EcoDrugPlus

Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1i-Like

Ensembl ID : ENSNBRG00000011909
Gene Symbol: LOC102785341
2 Cross references
183 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-1 Subunit-Like

Ensembl ID : ENSNBRG00000003883
Gene Symbol: LOC102783861
3 Cross references
194 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-3 Subunit-Like

Ensembl ID : ENSNBRG00000006869
Gene Symbol: LOC102777288
3 Cross references
179 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-3 Subunit-Like

Ensembl ID : ENSNBRG00000007709
Gene Symbol: LOC102789410
2 Cross references
190 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSNBRG00000004844
Gene Symbol: LOC102782134
3 Cross references
189 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit-Like

Ensembl ID : ENSNBRG00000003238
Gene Symbol: LOC102779311
3 Cross references
182 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-1-Like

Ensembl ID : ENSNBRG00000006276
Gene Symbol: LOC102795895
3 Cross references
226 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-2-Like

Ensembl ID : ENSNBRG00000019357
Gene Symbol: LOC102776731
3 Cross references
209 Possible Orthologues:

Wee1-Like Protein Kinase-Like

Ensembl ID : ENSNBRG00000015270
Gene Symbol: LOC102798485
3 Cross references
205 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSNBRG00000022609
Gene Symbol: XDH
3 Cross references
208 Possible Orthologues:

Ensembl ID : ENSNBRG00000018284
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSNBRG00000016107
Gene Symbol: -
Cross references: -
166 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).